Page last updated: 2024-10-28

ibuprofen and Leukemia L 1210

ibuprofen has been researched along with Leukemia L 1210 in 1 studies

Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine

Research Excerpts

ExcerptRelevanceReference
"Ibuprofen also did not increase brequinar's antitumor potency."1.28Effects of plasma protein binding displacement on the pharmacokinetics, tissue and tumor concentrations and efficacy of brequinar, a highly protein-bound antitumor agent. ( Aungst, BJ; Blake, JA; Dusak, BA; Rogers, NJ, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aungst, BJ1
Blake, JA1
Rogers, NJ1
Dusak, BA1

Other Studies

1 other study available for ibuprofen and Leukemia L 1210

ArticleYear
Effects of plasma protein binding displacement on the pharmacokinetics, tissue and tumor concentrations and efficacy of brequinar, a highly protein-bound antitumor agent.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 253, Issue:1

    Topics: Animals; Antineoplastic Agents; Aspirin; Biphenyl Compounds; Blood Proteins; Dose-Response Relations

1990